Enveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantI
ICONIQ
Activity from announced rounds
Activity in this selectionOct 16, 2026 · Sep 17, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $311M 1 disclosed · full round size, not this investor’s share